Leveraging postmortem imaging of a relatively large number of human MTL specimens with neuropathological diagnoses on the AD continuum, we characterize at an unprecedented level of detail, the 3-D probabilistic distribution of NFT burden at the different stages of AD and the regional effects of tau pathology on MTL neurodegeneration. This evidence concerns the gene MAPT and Alzheimer disease.